Idea EngineIdea EngineNASDAQ:CME CME Group (CME) Stock Price, News & Analysis $261.39 -1.48 (-0.56%) As of 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About CME Group Stock (NASDAQ:CME) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get CME Group alerts:Sign Up Key Stats Today's Range$260.71▼$264.9450-Day Range$241.74▼$268.3652-Week Range$190.70▼$273.42Volume2.38 million shsAverage Volume2.14 million shsMarket Capitalization$94.19 billionP/E Ratio27.03Dividend Yield1.91%Price Target$247.47Consensus RatingHold Company OverviewCME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. The company was founded in 1898 and is headquartered in Chicago, Illinois.Read More… Remove Ads CME Group Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks77th Percentile Overall ScoreCME MarketRank™: CME Group scored higher than 77% of companies evaluated by MarketBeat, and ranked 385th out of 951 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.1 / 5Analyst RatingHold Consensus RatingCME Group has received a consensus rating of Hold. The company's average rating score is 2.13, and is based on 4 buy ratings, 7 hold ratings, and 4 sell ratings.Amount of Analyst CoverageCME Group has been the subject of 10 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about CME Group's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings Growth4.77% Earnings GrowthEarnings for CME Group are expected to grow by 4.77% in the coming year, from $10.49 to $10.99 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of CME Group is 27.03, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.38.Price to Earnings Ratio vs. SectorThe P/E ratio of CME Group is 27.03, which means that it is trading at a more expensive P/E ratio than the Finance sector average P/E ratio of about 21.56.Price to Earnings Growth RatioCME Group has a PEG Ratio of 6.76. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioCME Group has a P/B Ratio of 3.56. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about CME Group's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.58% of the float of CME Group has been sold short.Short Interest Ratio / Days to CoverCME Group has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in CME Group has recently increased by 3.27%, indicating that investor sentiment is decreasing. Dividend2.5 / 5Dividend StrengthModerate Dividend YieldCME Group pays a meaningful dividend of 1.94%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthCME Group does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of CME Group is 51.71%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, CME Group will have a dividend payout ratio of 45.50% next year. This indicates that CME Group will be able to sustain or increase its dividend.Read more about CME Group's dividend. Sustainability and ESG2.9 / 5Environmental Score-0.26 Percentage of Shares Shorted1.58% of the float of CME Group has been sold short.Short Interest Ratio / Days to CoverCME Group has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in CME Group has recently increased by 3.27%, indicating that investor sentiment is decreasing. News and Social Media3.3 / 5News Sentiment0.89 News SentimentCME Group has a news sentiment score of 0.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Finance companies.News Coverage This WeekMarketBeat has tracked 66 news articles for CME Group this week, compared to 23 articles on an average week.Search Interest12 people have searched for CME on MarketBeat in the last 30 days. This is an increase of 33% compared to the previous 30 days.MarketBeat Follows17 people have added CME Group to their MarketBeat watchlist in the last 30 days. This is an increase of 113% compared to the previous 30 days. Company Ownership3.3 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, CME Group insiders have sold 40,731.28% more of their company's stock than they have bought. Specifically, they have bought $16,829.00 in company stock and sold $6,871,496.00 in company stock.Percentage Held by InsidersOnly 0.30% of the stock of CME Group is held by insiders.Percentage Held by Institutions87.75% of the stock of CME Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about CME Group's insider trading history. Receive CME Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CME Group and its competitors with MarketBeat's FREE daily newsletter. Email Address CME Stock News HeadlinesHow to Buy Gold Stock and Invest in Gold (CME)Wondering how to invest in gold, and more specifically, how to buy gold stock? Let MarketBeat help you learn how to buy gold stock.March 27, 2025 | marketbeat.comCME Group Inc. (NASDAQ:CME) Director Sells $2,600,000.00 in StockMarch 18, 2025 | insidertrades.comTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.April 16, 2025 | Porter & Company (Ad)The Outlook For S&P 500 Dividends In April 2025April 16 at 10:45 AM | seekingalpha.comCME Group (CME) Projected to Post Earnings on WednesdayApril 16 at 2:23 AM | americanbankingnews.comCME Group, S&P Group Agree to Sell OSTTRA to KKR in $3.1 Billion DealApril 15 at 4:33 PM | wsj.comCME Group (CME) in Madison Dividend Income Fund Q3 2024April 14 at 7:03 PM | gurufocus.comCME Group (CME) in Upslope Capital Q3 2024April 14 at 7:03 PM | gurufocus.comSee More Headlines CME Stock Analysis - Frequently Asked Questions How have CME shares performed this year? CME Group's stock was trading at $232.23 at the beginning of the year. Since then, CME shares have increased by 12.6% and is now trading at $261.39. View the best growth stocks for 2025 here. How were CME Group's earnings last quarter? CME Group Inc. (NASDAQ:CME) issued its quarterly earnings data on Wednesday, February, 12th. The financial services provider reported $2.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.46 by $0.06. CME Group had a net margin of 57.52% and a trailing twelve-month return on equity of 13.62%. Read the conference call transcript. How will CME Group's stock buyback program work? CME Group's Board of Directors initiated a share repurchase program on Thursday, December 5th 2024, which allows the company to buy back $3,000,000,000 in outstanding shares, according to EventVestor. This means that the company could repurchase up to 3.4% of its shares through open market purchases. Shares buyback programs are usually a sign that the company's management believes its stock is undervalued. Who are CME Group's major shareholders? Top institutional investors of CME Group include GAMMA Investing LLC (0.52%), Sarasin & Partners LLP (0.49%), Sarasin & Partners LLP (0.33%) and Rhumbline Advisers (0.20%). Insiders that own company stock include Terrence A Duffy, Bryan T Durkin, Julie Holzrichter, Sunil Cutinho, Hilda Harris Piell, Martin J Gepsman, Julie Winkler, Howard J Siegel, Elizabeth A Cook, Terry L Savage, Terry L Savage, Daniel R Glickman, Lynne Fitzpatrick, Ken Vroman, Timothy S Bitsberger, Derek Sammann, Suzanne Sprague, Timothy Francis Mccourt, Charles P Carey, Dennis Suskind and William R Shepard. View institutional ownership trends. How do I buy shares of CME Group? Shares of CME stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of CME Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that CME Group investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), DiamondRock Hospitality (DRH) and Southern First Bancshares (SFST). Company Calendar Record date for 1/16 Dividend12/27/2024Ex-Dividend for 1/16 Dividend12/27/2024Dividend Payable1/16/2025Last Earnings2/12/2025Record date for 3/26 Dividend3/07/2025Ex-Dividend for 3/26 Dividend3/07/2025Dividend Payable3/26/2025Today4/16/2025Next Earnings (Estimated)4/23/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorFinance Industry Security & commodity brokers, dealers, exchanges & services Sub-IndustrySpecialized Finance Current SymbolNASDAQ:CME CIK1156375 Webwww.cmegroup.com Phone(312) 930-1000Fax312-466-4410Employees3,460Year Founded1848Price Target and Rating Average Stock Price Target$247.47 High Stock Price Target$301.00 Low Stock Price Target$187.00 Potential Upside/Downside-6.2%Consensus RatingHold Rating Score (0-4)2.13 Research Coverage16 Analysts Profitability EPS (Most Recent Fiscal Year)$9.67 Trailing P/E Ratio27.29 Forward P/E Ratio25.15 P/E Growth6.76Net Income$3.53 billion Net Margins57.52% Pretax Margin74.08% Return on Equity13.62% Return on Assets2.81% Debt Debt-to-Equity Ratio0.10 Current Ratio1.01 Quick Ratio1.02 Sales & Book Value Annual Sales$6.13 billion Price / Sales15.51 Cash Flow$12.02 per share Price / Cash Flow21.95 Book Value$73.50 per share Price / Book3.59Miscellaneous Outstanding Shares360,357,000Free Float359,281,000Market Cap$95.08 billion OptionableOptionable Beta0.43 Social Links 10 Stocks Set to Soar in Spring 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free Report This page (NASDAQ:CME) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredFirst look: The $3,500 iPhoneDid you hear that just before Trump's tariffs took effect, Apple sent five cargo planes packed with MacBooks a...Stansberry Research | SponsoredMarkets in Chaos? Here’s What to Do.Wall Street's on edge with tariffs. And volatility? It's not slowing down. You've seen the headlines… Bu...Investors Alley | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CME Group Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CME Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.